Draft email to respondents for “Awardees Feedback Survey on NHLBI PAR-10-005 and PAR-13-002, NHLBI Clinical Trial Pilot Studies (R34)”
Dear Dr. XXXX:
You are receiving this email, because you received an NHLBI R34 award through NHLBI PAR-10-005 or PAR 13-002, entitled "NHLBI Clinical Trial Pilot Studies (R34)” and I need your assistance in providing up-to-date feedback on the program. I would appreciate your answers by XXXXX.
To help in this assessment, could you please answer the following questions related to your specific R34 proposal?
What information did you learn from this award?
Did you encounter unanticipated barriers?
What were these barriers?
Did they delay your progress?
Do you plan/have you planned a subsequent trial?
If not, why not?
If yes,
What is your time frame?
If yes, from whom do you plan to request funding?
Did the information gathered in the R34 lead you to modify your trial design or plans for implementation? If so, how?
Are you planning any publications based upon this award?
Did this program meet your needs?
If not, why not?
How would you modify the program to better meet your needs?
Thank you for your assistance in making NHLBI programs better suited to the community’s needs.
Sincerely,
Gail Weinmann, M.D. or designee
National Heart Lung and Blood Institute
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Windows User |
File Modified | 0000-00-00 |
File Created | 2021-01-25 |